Warburg Pincus Sells $229M in Sotera Health Stock as Part of Secondary Offering

summarizeSummary

Warburg Pincus & Co., a 10% owner and director, reported the sale of 15 million shares of Sotera Health common stock for $229.05 million, completing its portion of a previously announced secondary offering.

check_boxKey Events

• Major Insider Sale

  Warburg Pincus & Co., a 10% owner and director, disposed of 15,000,000 shares of Sotera Health common stock.

• Significant Proceeds

  The sale generated $229.05 million for Warburg Pincus.

• Part of Secondary Offering

  This transaction finalizes Warburg Pincus's participation in the 25 million share secondary offering initiated on March 4th and finalized on March 5th, which also included sales by GTCR affiliates.

• Reduced Stake

  Following this sale, Warburg Pincus's indirect holdings in Sotera Health are reduced to 19,102,952 shares.

auto_awesomeAnalysis

This Form 4 filing details Warburg Pincus & Co.'s significant sale of Sotera Health shares, which was part of a larger secondary offering by major institutional shareholders. The sale of 15 million shares for $229.05 million represents a substantial reduction in Warburg Pincus's stake, following the sale of 10 million shares by GTCR affiliates reported yesterday. While the offering was previously announced and finalized, this filing provides the specific insider reporting for Warburg Pincus, confirming their exit from a significant portion of their investment. Such large institutional sales can create an overhang on the stock, signaling a reduction in conviction from a major long-term holder.